|
|
Volumn 2, Issue 2, 2001, Pages 88-90
|
|
What is patent-worthy? Due to differing legal standards for patentability, applications for gene patents face different outcomes in various countries
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COMPLEMENTARY DNA;
DNA FRAGMENT;
PHOSPHOTRANSFERASE;
CELL DIVISION;
CONTROLLED STUDY;
DATA BASE;
DNA SEQUENCE;
EUROPE;
EXPRESSED SEQUENCE TAG;
GENE TECHNOLOGY;
GENETIC ANALYSIS;
HUMAN;
INFORMATION PROCESSING;
INTERNATIONAL COOPERATION;
JAPAN;
LAW;
LEGAL ASPECT;
LIVER FUNCTION;
MOLECULAR CLONING;
NOTE;
PATENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY CONTROL;
SEQUENCE ANALYSIS;
SEQUENCE HOMOLOGY;
STANDARDIZATION;
UNITED STATES;
BIOTECHNOLOGY;
DNA, COMPLEMENTARY;
EUROPE;
EXPRESSED SEQUENCE TAGS;
GENES;
JAPAN;
PATENTS;
UNITED STATES;
|
|
EID: 0035095663
PISSN: 1469221X
EISSN: None
Source Type: Journal
DOI: 10.1093/embo-reports/kve036 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
